|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of sales | |||||
| Gross profit | |||||
| Sales and marketing expenses | |||||
| Technology expenses | |||||
| General and administrative expenses | |||||
| Movements in credit losses allowance and write-offs | |||||
| Impairment loss on intangible assets | |||||
| Fair value movement on contingent consideration | |||||
| Operating (loss) profit | |||||
| Finance income | |||||
| Finance expenses | |||||
| (Loss) income before tax | |||||
| Income tax charge | |||||
| Net (loss) income for the year attributable to shareholders | |||||
| Other comprehensive income (loss) | |||||
| Items that are or may be reclassified subsequently to profit and loss | |||||
| Exchange differences on translating foreign currencies | |||||
| Cash flow hedge - effective portion of changes in fair value | |||||
| Cash flow hedges - reclassified to profit or loss | |||||
| Related tax | |||||
| Other comprehensive income (loss) for the year, net of tax | |||||
| Total comprehensive (loss) income for the year attributable to the shareholders | |||||
| Net (loss) income per share attributable to shareholders, basic (in usd per share) | |||||
| Net (loss) income per share attributable to shareholders, diluted (in usd per share) | |||||
Loading...